181 related articles for article (PubMed ID: 18473831)
21. A novel isoflavonoid from Millettia puguensis.
Kapingu MC; Mbwambo ZH; Moshi MJ; Magadula JJ; Cos P; Berghe DV; Maes L; Theunis M; Apers S; Pieters L; Vlietinck A
Planta Med; 2006 Nov; 72(14):1341-3. PubMed ID: 17054049
[TBL] [Abstract][Full Text] [Related]
22. The antimicrobial action of potential thiol reagents.
Zsolnai T
Zentralbl Bakteriol Orig; 1970; 14(4):507-17. PubMed ID: 5505430
[No Abstract] [Full Text] [Related]
23. A review of QSAR studies to discover new drug-like compounds actives against leishmaniasis and trypanosomiasis.
Castillo-Garit JA; Abad C; Rodríguez-Borges JE; Marrero-Ponce Y; Torrens F
Curr Top Med Chem; 2012; 12(8):852-65. PubMed ID: 22352913
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro antiprotozoal evaluation of substituted phenalenone analogues.
Rosquete LI; Cabrera-Serra MG; Piñero JE; Martín-Rodríguez P; Fernández-Pérez L; Luis JG; McNaughton-Smith G; Abad-Grillo T
Bioorg Med Chem; 2010 Jun; 18(12):4530-4. PubMed ID: 20472446
[TBL] [Abstract][Full Text] [Related]
25. Kinetoplastida: new therapeutic strategies.
Croft SL
Parasite; 2008 Sep; 15(3):522-7. PubMed ID: 18814734
[TBL] [Abstract][Full Text] [Related]
26. Purine and pyrimidine metabolism in parasitic protozoa.
Hassan HF; Coombs GH
FEMS Microbiol Rev; 1988 Feb; 4(1):47-83. PubMed ID: 3078769
[No Abstract] [Full Text] [Related]
27. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
Docampo R; Moreno SN
Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
[TBL] [Abstract][Full Text] [Related]
28. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy.
Bacchi CJ
J Protozool; 1981 Feb; 28(1):20-7. PubMed ID: 6788943
[No Abstract] [Full Text] [Related]
29. Effect of trypanocidal drugs on terminal respiration of Crithidia fasciculata.
Hill GC; Hutner SH
Exp Parasitol; 1968 Apr; 22(2):207-12. PubMed ID: 4231492
[No Abstract] [Full Text] [Related]
30. [New drugs for the treatment of human parasitic protozoa].
Dupouy-Camet J
Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
[TBL] [Abstract][Full Text] [Related]
31. New approaches from nanomedicine for treating leishmaniasis.
Gutiérrez V; Seabra AB; Reguera RM; Khandare J; Calderón M
Chem Soc Rev; 2016 Jan; 45(1):152-68. PubMed ID: 26487097
[TBL] [Abstract][Full Text] [Related]
32. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
[No Abstract] [Full Text] [Related]
33. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites.
Docampo R; Moreno SN
Curr Drug Targets Infect Disord; 2001 May; 1(1):51-61. PubMed ID: 12455233
[TBL] [Abstract][Full Text] [Related]
35. Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Ortega V; Giorgio S; de Paula E
J Liposome Res; 2017 Sep; 27(3):234-248. PubMed ID: 28874072
[TBL] [Abstract][Full Text] [Related]
36. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Cardona-G W; Yepes AF; Herrera-R A
Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
[TBL] [Abstract][Full Text] [Related]
37. Antiprotozoal compounds: state of the art and new developments.
Astelbauer F; Walochnik J
Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
[TBL] [Abstract][Full Text] [Related]
38. Leishmaniasis drug discovery: recent progress and challenges in assay development.
Zulfiqar B; Shelper TB; Avery VM
Drug Discov Today; 2017 Oct; 22(10):1516-1531. PubMed ID: 28647378
[TBL] [Abstract][Full Text] [Related]
39. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
40. Amphibian antimicrobial peptides and Protozoa: lessons from parasites.
Rivas L; Luque-Ortega JR; Andreu D
Biochim Biophys Acta; 2009 Aug; 1788(8):1570-81. PubMed ID: 19046939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
